Trials / Conditions / Acute Megakaryoblastic Leukemia
Acute Megakaryoblastic Leukemia
4 registered clinical trials studyying Acute Megakaryoblastic Leukemia.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | Cord Blood Transplant With Dilanubicel for the Treatment of HIV Positive Hematologic Cancers NCT04083170 | Fred Hutchinson Cancer Center | Phase 2 |
| Unknown | Alisertib in Treating Patients With Myelofibrosis or Relapsed or Refractory Acute Megakaryoblastic Leukemia NCT02530619 | Northwestern University | N/A |
| Completed | Donor Natural Killer Cells and Donor Stem Cell Transplant in Treating Patients With High Risk Myeloid Malignan NCT01823198 | M.D. Anderson Cancer Center | Phase 1 / Phase 2 |
| Active Not Recruiting | Vorinostat and Azacitidine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia NCT00392353 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |